Furusu A, Miyazaki M, Abe K, Tsukasaki S, Shioshita K, Sasaki O, Miyazaki K, Ozono Y, Koji T, Harada T, Sakai H, Kohno S
Second Department of Internal Medicine, Nagasaki University School of Medicine, Japan.
Kidney Int. 1998 Jun;53(6):1760-8. doi: 10.1046/j.1523-1755.1998.00907.x.
The presence of nitric oxide (NO) in the kidney has been implicated in the pathogenesis of human glomerulonephritis. However, the exact type of glomerular cells that express NO synthase (NOS) and the NOS isoform involved in the local production of NO has not been identified in the human diseased kidney. We examined the expression of three isoforms of NOS, inducible NOS (iNOS), endothelial NOS (eNOS) and brain NOS (bNOS) in the renal tissue of patients with IgA nephropathy (IgAN, N = 10), lupus nephritis (LN, N = 5), membranous nephropathy (MN, N = 5) and minimal change nephrotic syndrome (MCNS, N = 5). Sections were immunostained and the correlation between the expression of each NOS and the degree of glomerular injury in that section was also examined. Normal portions of surgically resected kidneys served as controls. eNOS was present in glomerular endothelial cells and endothelium of cortical vessels in the control and diseased kidneys. iNOS was localized in mesangial cells, glomerular epithelial cells and infiltrating cells in the diseased glomeruli, whereas immunostaining for iNOS was hardly detected in control kidneys. In addition, the expression pattern of eNOS in each glomerulus was the reverse of that of iNOS. In IgAN and LN, the extent of staining for eNOS correlated negatively with the degree of glomerular injury, while the extent of staining for iNOS correlated positively with the degree of glomerular injury in the same tissues. bNOS was not detected in normal or nephritic glomeruli. Our results indicate the presence of a NO pathway in human diseased kidney, and suggest that NO derived from eNOS and iNOS may be involved in the progression of renal diseases and that NO derived from each NOS may play an important role in different way in human inflamed glomeruli.
肾脏中一氧化氮(NO)的存在与人类肾小球肾炎的发病机制有关。然而,在人类患病肾脏中,尚未确定表达一氧化氮合酶(NOS)的具体肾小球细胞类型以及参与局部NO产生的NOS同工型。我们检测了免疫球蛋白A肾病(IgAN,N = 10)、狼疮性肾炎(LN,N = 5)、膜性肾病(MN,N = 5)和微小病变肾病综合征(MCNS,N = 5)患者肾组织中三种NOS同工型,即诱导型NOS(iNOS)、内皮型NOS(eNOS)和脑型NOS(bNOS)的表达。对切片进行免疫染色,并检测每个切片中各NOS表达与肾小球损伤程度之间的相关性。手术切除肾脏的正常部分作为对照。在对照和患病肾脏中,eNOS存在于肾小球内皮细胞和皮质血管内皮中。iNOS定位于患病肾小球的系膜细胞、肾小球上皮细胞和浸润细胞中,而在对照肾脏中几乎检测不到iNOS的免疫染色。此外,每个肾小球中eNOS的表达模式与iNOS相反。在IgAN和LN中,eNOS的染色程度与肾小球损伤程度呈负相关,而在相同组织中iNOS的染色程度与肾小球损伤程度呈正相关。在正常或肾炎性肾小球中未检测到bNOS。我们的结果表明人类患病肾脏中存在NO途径,并提示源自eNOS和iNOS的NO可能参与肾脏疾病的进展,且源自每种NOS的NO可能在人类炎症性肾小球中以不同方式发挥重要作用。